BioCentury
ARTICLE | Clinical News

Gardasil: Postmarketing study data

July 20, 2015 7:00 AM UTC

The U.S. postmarketing Sentinel study in >650,000 females ages 9-26 showed that there was no evidence of an increased risk of VTE in the 28 days after receiving any of the 3 doses of Gardasil. There w...